SHMT2 and thyroid gland carcinoma: Since methylation of PTEN promoter has been reported in thyroid cancer and SHMT2 catalyzes the generation of methyl donor SAM [12, 25, 26], we hypothesized that SHMT2 represses PTEN expression via DNA methylation.